Effects of daily low dose mifepristone on endometrial maturation and proliferation

Human Reproduction

Volumn 11, Issue 11, 1996, Pages 2518-2526

  Cameron, Sharon T ^a   Critchley, Hilary O D ^a   Thong, K Joo ^a   Buckley, C Hilary ^b   Williams, Alistair R ^c   Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Endometrium; Implantation; Mifepristone; Proliferation

Indexed keywords

CYCLINE; ESTRADIOL; ESTROGEN RECEPTOR; GESTAGEN; KI 67 ANTIGEN; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROGESTERONE RECEPTOR; TESTOSTERONE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ESTRADIOL BLOOD LEVEL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MITOSIS RATE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OVULATION INHIBITION; PROGESTERONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 0030457431     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019151     Document Type: Article

References (32)

1. Adams, J.L., Polson, D.W. and Franks, S. (1986) Presence of polycystic ovaries in anovulatory women and patients with idiopathic hirsutism. Br. Med. J., 243, 355-359.
2. Baird, D.T. (1993) Antigestogens. Br. Med. Bull., 49, 73-87.
3. Batista, M.C., Cartledge, T.P., Zellmer, A.W. et al. (1992) Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy. Am. J. Obstet. Gynecol. 157, 77-126.
4. Bravo, R., Frank, R., Blundell, P.A. and MacDonald-Bravo, H. (1987) Cyclin/ PCNA is the auxiliary protein of DNA polymerase-γ. Nature, 326, 515-517.
5. Buckley, C.H. and Fox, H. (1991) Functional disorders of the endometrium. In Buckley, C.H. and Fox, H. (eds), Biopsy Pathology of the Endometrium. Chapman and Hall Medical, London, pp. 51-67.
6. Cameron, ST., Thong, K.J. and Baird DT. (1995) Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth. Clin. Endocrinol., 43, 407-414.
7. Cameron, S.T., Critchley, H.O.D., Buckley, C.H. et al. (1996) The effects of post-ovulatory administration of onapristone on the development of a secretory endometrium. Hum. Reprod., 11, 40-49.
8. Cordell, J.L., Falini, B., Erber W.N. et al. (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem., 32, 219-229.
9. Critchley, H.O.D., Bailey, D.A., Au, C.L. et al. (1993) Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum Reprod., 8, 1632-1639.
10. Croxatto, H.B., Salvatierra, A.M., Croxatto, H.D., and Fuentealba. B. (1993) Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum. Reprod., 8, 201-207.
11. Dowsett, M., Howell, R., Salter, J. et al. (1995) Effects of the pure anti-oestrogen ICI 182780 on estrogen receptors, progesterone receptors and Ki67 antigen in human endometrium in vivo. Hum. Reprod., 10, 262-267.
12. Ferenczy, A., Bertrand, G. and Gelfand, M.M. (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am. J. Obstet. Gynecol., 133, 859-867
13. Garcia, E., Bouchard, P., De Brux, J. et al. (1988) Use of immunohistochemistry of progesterone and estrogen receptors for endometrial dating. J. Clin. Endocrinol. Metab., 67, 80-87.
14. Gerdes, J., Carsten Schlueter, L.L., Duchrow, M. et al. (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol., 138, 867-73.
15. Goreki, J., Stormshak, Harris J. and Wertz, N. (1977) Hormone regulation of growth: stimulatory and inhibitory influences of estrogens on DNA synthesis. J. Toxicol. Environ. Health, 3, 271-279.
16. Katkam, R.R., Gopalkrishnan, K., Chwalisz, K. et al. (1995) Onapristone (ZK 98299): a potential antiprogestin for endometrial contraception. Am. J. Obstet. Gynecol., 173, 779-787.
17. Kekkonen, R., Lahteenmaki, P., Luukkainen, R. and Tuominen, J. (1993) Sequential regimen of the antiprogesterone RU 486 and synthetic progestin for contraception. Fertil. Steril., 60, 610-615.
18. Ledger, W.L., Sweeting, V.M., Hillier, H. and Baird, D.T. (1992) Inhibition of ovulation by low-dose mifepristone (RU 486). Hum. Reprod., 7, 945-950.
19. 1. Breast Can. Res. Treat., 17, 155.
20. Murphy, A.A., Kettel, M.L., Morales, A.J. et al. (1995) Endometrial effects of long-term low-dose administration of RU486. Fertil. Steril., 63, 761-766.
21. Noyes, R.W., Hertig, A.T. and Rock, J. (1950) Dating the endometrial biopsy. Fertil. Steril., 1, 3-25.
22. Neulen, J., Williams, R.F. and Hogden, G.D. (1990) RU 486 (mifepristone): induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. J. Clin. Endocrinol. Melab., 71, 1074-1075.
23. Rodgers, P.A.W., Au, C.L. and Affandi, B. (1993) Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum. Reprod., 8, 1396-1404.
24. Snijders, M.P.M.L., de Goeij, A.F.P.M., Debets-Te Baerts, M.J.C. et al. (1992) Immunohistochemical analysis of estrogen and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J. Reprod. Fertil., 94, 363-371.
25. Sutherland, R.L., Watts, C.K.W. and Musgrove, E.A. (1995) Cell cycle control by steroid hormones in breast cancer: implications for endocrine resistance. Endo-Rel. Cancer, 2, 87-96.
26. UK Multicentre Trial (1990) The efficacy and tolerance of RU486 and prostaglandins in first trimester termination of pregnancy. Br. J. Obstet. Gynaecol., 97, 480-486.
27. van Uem, J.F.H.M., Hsiu, J.G., Chillik, C.F. et al. (1989) Contraceptive potential of RU486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation. Contraception, 40, 171-184.
28. Verheijen, R., Kuijpers, H.J.H., Schlingemann, R.O. et al. (1989) Ki 67 detects a nuclear matrix-associated proliferation-related antigen-I. Intracellular localization during interphase. J. Cell Sci., 92, 123-130.
29. Wijisman, J.H., Van Dierendonck, J.-H., Keijzer, R. et al. (1992) Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J. Pathol., 168, 75-83.
30. Wingfield, M., Macpherson, A., Healy, D.L. and Rodgers, P.A.W. (1995) Cell proliferation is increased in the endometrium of women with endometriosis. Fertil. Steril., 64, 340-346.
31. Wolf, J.P., Hsiu, J.G., Anderson, T.L. et al. (1989) Non-competitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinising hormone surge and the proliferative action of oestradiol on endometrium in castrate monkeys. Fertil. Steril., 52, 1055-1060.
32. Yong, E.L., Glasier, A.F., Hillier, H. et al. (1992) Effect of cyclofenil on hormonal dynamics, follicular development and cervical mucus in normal and oligomenorrhoeic women. Hum. Reprod., 7, 39-43.